Drugs Made In America Acquisition Ii Corp (DMIIU) Return on Investment ROI from the second quarter of 2026 to second quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Drugs Made In America Acquisition Ii Corp   (NASDAQ: DMIIU)
    Sector • Financial    Industry • Blank Checks
   Industry • Blank Checks
   Sector • Financial


Drugs Made In America Acquisition Ii's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Drugs Made In America Acquisition Ii's ROI in the second quarter of 2026?
Drugs Made In America Acquisition Ii Corp achieved a return on average invested assets (ROI) of 100.33 % in its second quarter of 2026, this is above DMIIU's average return on investment of 0%.
Drugs Made In America Acquisition Ii Corp invested over the 12 months ending in its second quarter of 2026 $507 million

ROI fell compared to the first quarter of 2026, despite the net income growth of 1.35% from the first quarter of 2026.

Within the Financial sector Drugs Made In America Acquisition Ii Corp achieved the highest return on investment. While the total ranking for ROI remained the same, compared to the first quarter of 2026 at no. .

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
III. Quarter
Y / Y Investment Change TTM - - - - -
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 513 509 505 501 0
Return On Investment (TTM) 100.33 % 133.18 % 198.86 % 399.27 % -
DMIIU's Overall Ranking # # # # #
Seq. Investment Change TTM 33.9 % 50.63 % 100.78 % - -
Seq. Net Income Change TTM 0.88 % 0.88 % 0 % - -
Net Income (TTM) in Millions 509 504 500 500 0

DMIIU Company Profile >> Back to DMIIU Roi Comparisons >> See Annual DMIIU Return On Investment



Return On Investment DMIIU's Ranking
Within: No.
Industry #
Sector #
Overall #

Return On Investment Statistics
High Average Low
0 %
0 %
0 %
 







Financial Statements
Drugs Made In America Acquisition Ii's II. Quarter Investments $ 513 Millions DMIIU's Balance sheet
Drugs Made In America Acquisition Ii's II. Quarter Income $ 4 Millions Quarterly DMIIU's Income Statement
DMIIU's Income by Division See DMIIU's Income by Division


DMIIU Annual Return On Investment (Dec 31 2025)
2025



Total Investments in Millions 487 0 0 0 0
Y / Y Investment Growth - - - - -
Net Income in Millions 4 0 0 0 0
Y / Y Net Income Growth - - - - -
Annual Return On Investment 0.86 % - - - -


Annual Roi Comment
In the fiscal year 2025 ROI deteriorated to 0.86 %, despite net income growth.

Definition and Formula of Return on Investment

Other ROI Ratios
Blank Checks Industry Roi Trends and Statistics
Financial Sector Return On Investment Statistics
Roi Trends for overall market
DMIIU's Roi Ratio versus Blank Checks Industry, Financial Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for DMIIU's Competitors
Subscribers only: Roi for Drugs Made In America Acquisition Ii's Suppliers
Subscribers only: Return On Investment for DMIIU's Customers

Other Ratios
DMIIU's Roa DMIIU's Inventory Turnover Ratio DMIIU's Growth Rates DMIIU's Dividend Statistics
DMIIU's Profitability Ratios DMIIU's Asset Turnover Ratio DMIIU's Dividend Growth
DMIIU's Roe DMIIU's Valuation Ratios DMIIU's Financial Strength Ratios DMIIU's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Financial Sector ROI
Marvion Inc.  262.54 %
Keen Vision Acquisition Corporation  183.06 %
Rising Dragon Acquisition Corp   147.96 %
Columbus Acquisition Corp  140.31 %
Selectis Health Inc   126.06 %
Tavia Acquisition Corp   121.51 %
Etf Managers Group Commodity Trust I  119.34 %
Managed Futures Premier Graham L p   109.28 %
Ceres Orion L p   109.01 %
Ceres Tactical Systematic L p   107.44 %
United States Gasoline Fund Lp  64.98 %
United States 12 month Oil Fund Lp  55.68 %
Dave Inc   48.43 %
United States Oil Fund Lp  46.99 %
United States 12 month Natural Gas Fund Lp  45.69 %
Abrdn Silver Etf Trust  38.14 %
Suro Capital Corp   34.86 %
Site Centers Corp   31.22 %
Corvel Corporation  29.42 %
Oscar Health Inc   27.79 %
Sei Investments Company  27.54 %
Lendingtree inc   24.24 %
Artisan Partners Asset Management Inc   23.45 %
Erie Indemnity Company  23.09 %
Gigcapital7 Corp   22.40 %
Moody s Corporation  21.89 %
Evercore Inc   21.62 %
Invesco Db Oil Fund  21.16 %
Brookfield Asset Management Ltd   21.04 %
Cohen and Steers Inc   21.03 %

Date modified: 2026-09-26T07:43:57+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.